Health Care & Life Sciences » Biotechnology | Genera Biosystems Ltd.

Genera Biosystems Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,462.00
2,789.50
3,084.10
3,087.80
4,481.20
Depreciation, Depletion & Amortization
690.30
600.70
700.20
722.90
701.00
Other Funds
970.70
1,332.40
994.90
1,311.40
2,553.60
Funds from Operations
800.90
856.40
1,389.00
1,053.40
1,226.60
Changes in Working Capital
45.30
100.00
20.80
287.90
58.90
Net Operating Cash Flow
846.30
956.40
1,368.20
765.60
1,167.60
Capital Expenditures
230.40
435.80
609.00
252.80
158.70
Net Investing Cash Flow
230.40
435.80
609.00
252.80
158.70
Issuance/Reduction of Debt, Net
1,000.00
-
550.00
1,172.70
-
Net Financing Cash Flow
1,540.90
2,286.20
556.30
1,172.70
1,184.40
Net Change in Cash
464.20
894.00
1,420.90
154.30
141.90
Free Cash Flow
847.00
1,096.70
1,697.40
848.10
1,174.20
Change in Capital Stock
540.90
2,286.20
6.30
-
1,027.00

About Genera Biosystems

View Profile
Address
Small Technologies Cluster
Scoresby Victoria (VIC) 3179
Australia
Employees -
Website http://www.generabiosystems.com
Updated 07/08/2019
Genera Biosystems Ltd. is a molecular diagnostics company, which engages in the development, manufacture, and distribution of polymerase chain reaction (PCR) molecular diagnostic tests. Its products include AmpaSand, PapType, and RTI-plex. The company was founded by Karl Poetter on November 6, 2001 and is headquartered in Scoresby, Australia.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.